Are there any notable changes in the company's capital allocation, such as capex, R&D spending, or share buybacks, that could impact the stock price?

Fundamental view – The brief press release for Guerrilla RF’s Q2‑2025 earnings does not contain any explicit statements about changes to capital‑allocation policies such as new capital‑expenditure programs, elevated R&D budgets, or announced share‑repurchase plans. In the absence of disclosed revisions, the company’s capital structure appears unchanged from the prior quarter. That said, Guerrilla’s historical practice has been to reinvest a sizable portion of cash flow into its RF‑engineer‑focused product pipeline and to fund modest buy‑backs when cash generation exceeds the operating‑cash‑needs. Investors should therefore review the detailed 10‑Q filing (or the full earnings press release) for any subtle “increase in R&D expense” line‑item or “cap‑ex allocation for new production line” that could signal a strategic shift.

Trading implications – Because no concrete allocation change is disclosed, the stock’s near‑term price action will likely be driven by the earnings beat/miss and forward‑guidance rather than a capital‑allocation catalyst. Technical charts show GUER trading near its 50‑day moving average with a modest bullish bias; the stock holds support around $2.10 and faces resistance near $2.45, where volume historically spikes on earnings releases. Until the detailed filing confirms a shift (e.g., a $10 M cap‑ex rollout or a $5 M share buyback), keep a “watch‑list” stance: consider buying on a pull‑back to support if earnings beat expectations and cash flow remains healthy, or consider a short‑term sell‑off if the company signals a slowdown in R&D spend, which could be interpreted as a weakening of future growth momentum. Monitoring the next earnings call and any accompanying investor presentation for concrete cap‑ex or buy‑back guidance will be key to refining the trade.